Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 153.27
-0.013 %
$ 15.5 B
Market Cap
40.87
P/E
NBIX - OTHER LONG-TERM ASSETS
Other Long-term Assets NBIX - Neurocrine Biosciences, Inc.
49.6 M
LAST VALUE
235.75%
2 YEAR CAGR
55.38%
5 YEAR CAGR
27.29%
10 YEAR CAGR